Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin RB Rothman, MH Baumann, CM Dersch, DV Romero, KC Rice, FI Carroll, ... Synapse 39 (1), 32-41, 2001 | 1114 | 2001 |
A proposal for the classification of sigma binding sites R Quirion Trends Pharmacol Sci 13, 85-86, 1992 | 957 | 1992 |
Salvinorin A: a potent naturally occurring nonnitrogenous κ opioid selective agonist BL Roth, K Baner, R Westkaemper, D Siebert, KC Rice, SA Steinberg, ... Proceedings of the National Academy of Sciences 99 (18), 11934-11939, 2002 | 939 | 2002 |
Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications RB Rothman, MH Baumann, JE Savage, L Rauser, A McBride, ... Circulation 102 (23), 2836-2841, 2000 | 831 | 2000 |
Monoamine transporters and psychostimulant drugs RB Rothman, MH Baumann European journal of pharmacology 479 (1-3), 23-40, 2003 | 614 | 2003 |
The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue MH Baumann, MA Ayestas, JS Partilla, JR Sink, AT Shulgin, PF Daley, ... Neuropsychopharmacology 37 (5), 1192-1203, 2012 | 510 | 2012 |
Powerful cocaine-like actions of 3, 4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products MH Baumann, JS Partilla, KR Lehner, EB Thorndike, AF Hoffman, M Holy, ... Neuropsychopharmacology 38 (4), 552-562, 2013 | 481 | 2013 |
Depressive-like effects of the κ-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats WA Carlezon, C Béguin, JA DiNieri, MH Baumann, MR Richards, ... Journal of Pharmacology and Experimental Therapeutics 316 (1), 440-447, 2006 | 471 | 2006 |
N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity NH Jensen, RM Rodriguiz, MG Caron, WC Wetsel, RB Rothman, BL Roth Neuropsychopharmacology 33 (10), 2303-2312, 2008 | 375 | 2008 |
3, 4-methylenedioxymethamphetamine (MDMA,“Ecstasy”) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro V Setola, SJ Hufeisen, KJ Grande-Allen, I Vesely, RA Glennon, B Blough, ... Molecular pharmacology 63 (6), 1223-1229, 2003 | 365 | 2003 |
Rapid Communication: Attenuation of Methamphetamine‐Induced Neurotoxicity in Copper/Zinc Superoxide Dismutase Transgenic Mice JL Cadet, P Sheng, S All, R Rothman, E Carlson, C Epstein Journal of neurochemistry 62 (1), 380-383, 1994 | 318 | 1994 |
3, 4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings MH Baumann, X Wang, RB Rothman Psychopharmacology 189, 407-424, 2007 | 305 | 2007 |
Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(. alpha. R)-. alpha.-((2S, 5R)-4-Allyl-2, 5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N, N … SN Calderon, RB Rothman, F Porreca, JL Flippen-Anderson, RW McNutt, ... Journal of medicinal chemistry 37 (14), 2125-2128, 1994 | 292 | 1994 |
An opioid agonist that does not induce μ-opioid receptor—arrestin interactions or receptor internalization CE Groer, K Tidgewell, RA Moyer, WW Harding, RB Rothman, ... Molecular pharmacology 71 (2), 549-557, 2007 | 280 | 2007 |
SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. EJ Bilsky, SN Calderon, T Wang, RN Bernstein, P Davis, VJ Hruby, ... Journal of Pharmacology and Experimental Therapeutics 273 (1), 359-366, 1995 | 274 | 1995 |
Mu and delta receptors: their role in analgesia and in the differential effects of opioid peptides on analgesia JL Vaught, RB Rothman, TC Westfall Life sciences 30 (17), 1443-1455, 1982 | 264 | 1982 |
Dose-related neurobehavioral effects of chronic cocaine use KI Bolla, R Rothman, JL Cadet The Journal of neuropsychiatry and clinical neurosciences 11 (3), 361-369, 1999 | 260 | 1999 |
N-substituted piperazines abused by humans mimic the molecular mechanism of 3, 4-methylenedioxymethamphetamine (MDMA, or ‘Ecstasy’) MH Baumann, RD Clark, AG Budzynski, JS Partilla, BE Blough, ... Neuropsychopharmacology 30 (3), 550-560, 2005 | 259 | 2005 |
Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates: implications for primary pulmonary hypertension RB Rothman, MA Ayestas, CM Dersch, MH Baumann Circulation 100 (8), 869-875, 1999 | 254 | 1999 |
A review of the role of anti‐opioid peptides in morphine tolerance and dependence RB Rothman Synapse 12 (2), 129-138, 1992 | 216 | 1992 |